Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 8, 2011, Pages 973-980

  Lambiase, A ^a   Catania, M R ^a   Del Pezzo, M ^a   Rossano, F ^a   Terlizzi, V ^a   Sepe, A ^a   Raia, V ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NETILMICIN; PIPERACILLIN; TAZOBACTAM; TETRACYCLINE;

ACHROMOBACTER XYLOSOXIDANS; ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BODY MASS; CHILD; CHRONIC DISEASE; CLINICAL EVALUATION; CLONAL SPECIES; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA FINGERPRINTING; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIDRUG RESISTANCE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; PULSED FIELD GEL ELECTROPHORESIS; RESPIRATORY TRACT INFECTION; RESTRICTION MAPPING; SCHOOL CHILD; SEQUENCE HOMOLOGY; SPUTUM CULTURE;

ACHROMOBACTER DENITRIFICANS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; COMORBIDITY; CYSTIC FIBROSIS; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS; HUMANS; INFANT; ITALY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; YOUNG ADULT;

EID: 80051543764     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1182-5     Document Type: Article

References (37)

1. JL Burns J Emerson JR Stapp DL Yim J Krzewinski L Louden BW Ramsey CR Clausen 1998 Microbiology of sputum from patients at cystic fibrosis centers in the United States Clin Infect Dis 27 1 158 163 9675470 10.1086/514631 1:STN:280:DyaK1czktVSksg%3D%3D (Pubitemid 28334435)
2. JB Lyczak CL Cannon GB Pier 2002 Lung infections associated with cystic fibrosis Clin Microbiol Rev 15 2 194 222 11932230 10.1128/CMR.15.2.194-222.2002 1:CAS:528:DC%2BD38XjslGrurk%3D (Pubitemid 34303763)
3. S Rajan L Saiman 2002 Pulmonary infections in patients with cystic fibrosis Semin Respir Infect 17 1 47 56 11891518 10.1053/srin.2002.31690 (Pubitemid 34233391)
4. L Saiman J Siegel 2004 Infection control in cystic fibrosis Clin Microbiol Rev 17 1 57 71 14726455 10.1128/CMR.17.1.57-71.2004 (Pubitemid 38120929)
5. A Lambiase V Raia M Del Pezzo A Sepe V Carnovale F Rossano 2006 Microbiology of airway disease in a cohort of patients with cystic fibrosis BMC Infect Dis 6 4 16405721 10.1186/1471-2334-6-4
6. B Frederiksen C Koch N Høiby 1999 Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995) Pediatr Pulmonol 28 3 159 166 10495331 10.1002/(SICI)1099-0496(199909)28: 3<159::AID-PPUL1>3.0.CO;2-1 1:STN:280:DyaK1MvivFSmtg%3D%3D (Pubitemid 29420280)
7. A Lambiase V Raia S Stefani A Sepe P Ferri P Buonpensiero F Rossano M Del Pezzo 2007 Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis J Microbiol 45 3 275 279 17618236 1:CAS:528:DC%2BD2sXos1Kjsrw%3D (Pubitemid 47037764)
8. CH Goss K Otto ML Aitken GD Rubenfeld 2002 Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis Am J Respir Crit Care Med 166 3 356 361 12153970 10.1164/rccm.2109078 (Pubitemid 34864426)
9. K Tan SP Conway KG Brownlee C Etherington DG Peckham 2002 Alcaligenes infection in cystic fibrosis Pediatr Pulmonol 34 101 104 12112775 10.1002/ppul.10143 (Pubitemid 34809520)
10. L Liu T Coenye JL Burns PW Whitby TL Stull JJ LiPuma 2002 Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients J Clin Microbiol 40 1210 1213 11923333 10.1128/JCM.40.4.1210-1213.2002 1:CAS:528: DC%2BD38XjtlCnu78%3D (Pubitemid 34279877)
11. N Bakare V Rickerts J Bargon G Just-Nübling 2003 Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis Mycoses 46 1-2 19 23 12588478 10.1046/j.1439-0507.2003. 00830.x 1:STN:280:DC%2BD3s%2FnvVCisg%3D%3D
12. KN Olivier DJ Weber JH Lee A Handler G Tudor PL Molina J Tomashefski MR Knowles Nontuberculous Mycobacteria in Cystic Fibrosis Study Group 2003 Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease Am J Respir Crit Care Med 167 6 835 840 12433669 10.1164/rccm.200207-679OC (Pubitemid 36801770)
13. T Coenye J Goris T Spilker P Vandamme JJ LiPuma 2002 Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov J Clin Microbiol 40 6 2062 2069 12037065 10.1128/JCM.40.6.2062-2069.2002 (Pubitemid 34596385)
14. A Lambiase M Del Pezzo V Raia A Sepe P Ferri F Rossano 2007 Chryseobacterium respiratory tract infections in patients with cystic fibrosis J Infect 55 6 518 23 17889369 10.1016/j.jinf.2007.08.002 (Pubitemid 350082468)
15. A Lambiase F Rossano M Del Pezzo V Raia A Sepe F de Gregorio MR Catania 2009 Sphingobacterium respiratory tract infection in patients with cystic fibrosis BMC Res Notes 2 262 20030840 10.1186/1756-0500-2-262
16. B Cimon J Carrère JF Vinatier JP Chazalette D Chabasse JP Bouchara 2000 Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis Eur J Clin Microbiol Infect Dis 19 1 53 56 10706182 10.1007/s100960050011 1:STN:280:DC%2BD3c7mvVKquw%3D%3D (Pubitemid 30093384)
17. A Defontaine R Zouhair B Cimon J Carrère E Bailly F Symoens M Diouri JN Hallet JP Bouchara 2002 Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis J Clin Microbiol 40 6 2108 2114 12037073 10.1128/JCM.40.6.2108-2114.2002 1:CAS:528:DC%2BD38XltFOntL8%3D (Pubitemid 34596393)
18. B Cimon J Carrère JP Chazalette JF Vinatier D Chabasse JP Bouchara 1999 Chronic airway colonization by Penicillium emersonii in a patient with cystic fibrosis Med Mycol 37 4 291 293 10421865 1:STN:280:DyaK1Mzlt1Clsg%3D%3D (Pubitemid 29364146)
19. M Pihet J Carrère B Cimon D Chabasse L Delhaes F Symoens JP Bouchara 2009 Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis-a review Med Mycol 47 4 387 397 19107638 10.1080/13693780802609604
20. E Yabuuchi Y Kawamura Y Kosako T Ezaki 1998 Emendation of genus Achromobacter and Achromobacter xylosoxidans (Yabuuchi and Yano) and proposal of Achromobacter ruhlandii (Packer and Vishniac) comb. nov., Achromobacter piechaudii (Kiredjian et al.) comb. nov., and Achromobacter xylosoxidans subsp. denitrificans (Rüger and Tan) comb. nov. Microbiol Immunol 42 429 438 9688077 1:CAS:528:DyaK1cXkvVKlsr4%3D
21. R Manfredi A Nanetti M Ferri F Chiodo 1997 Bacteremia and respiratory involvement by Alcaligenes xylosoxidans in patients infected with the human immunodeficiency virus Eur J Clin Microbiol Infect Dis 16 933 938 9495677 10.1007/BF01700563 1:STN:280:DyaK1c7lsFSltw%3D%3D (Pubitemid 28046153)
22. H Vu-Thien JC Darbord D Moissenet C Dulot JB Dufourcq P Marsol A Garbarg-Chenon 1998 Investigation of an outbreak of wound infections due to Alcaligenes xylosoxidans transmitted by chlorhexidine in a burns unit Eur J Clin Microbiol Infect Dis 17 724 726 9865987 10.1007/s100960050168 1:STN:280:DyaK1M%2FotFGrtw%3D%3D (Pubitemid 29218996)
23. D Tena R Carranza JR Barberá S Valdezate JM Garrancho M Arranz JA Sáez-Nieto 2005 Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a hemodialysis unit Eur J Clin Microbiol Infect Dis 24 727 732 16283217 10.1007/s10096-005-0028-4 1:STN:280:DC%2BD2MnksVGgug%3D%3D (Pubitemid 41752068)
24. H Peltroche-Llacshuanga H Kentrup G Haase 1998 Persistent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis Eur J Clin Microbiol Infect Dis 17 132 134 9629983 1:STN:280: DyaK1c3ptF2gtw%3D%3D (Pubitemid 28306126)
25. H Vu-Thien D Moissenet M Valcin C Dulot G Tournier A Garbarg-Chenon 1996 Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center Eur J Clin Microbiol Infect Dis 15 876 879 8997562 10.1007/BF01691221 1:STN:280:DyaK2s7ltFGrsg%3D%3D (Pubitemid 26421623)
26. L Saiman Y Chen S Tabibi P San Gabriel J Zhou Z Liu L Lai S Whittier 2001 Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis J Clin Microbiol 39 3942 3945 11682511 10.1128/JCM.39.11.3942-3945.2001 1:CAS:528:DC%2BD3MXoslWnt7g%3D (Pubitemid 33029764)
27. M Kanellopoulou S Pournaras H Iglezos N Skarmoutsou E Papafrangas AN Maniatis 2004 Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone Eur J Clin Microbiol Infect Dis 23 336 339 15024624 10.1007/s10096-004-1105-9 1:STN:280:DC%2BD2c3gtVWnsA%3D%3D (Pubitemid 38669944)
28. T Raso O Bianco B Grosso M Zucca D Savoia 2008 Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients APMIS 116 837 841 19024606 10.1111/j.1600-0463.2008.00995.x
29. BW Ramsey 1996 Management of pulmonary disease in patients with cystic fibrosis N Engl J Med 335 179 188 8657217 10.1056/NEJM199607183350307 1:CAS:528:DyaK28XkvFSgtLo%3D (Pubitemid 26249456)
30. Saiman L, MacDonald NE, Whittier S (1996) The microbiological basis for antimicrobial therapy. In: Proceedings of the 10th Annual North American Cystic Fibrosis Conference, Orlando, FL, October 1996. Cystic Fibrosis Foundation
31. B Frederiksen C Koch N Høiby 1999 Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995) Pediatr Pulmonol 28 159 166 10495331 10.1002/(SICI)1099-0496(199909)28:3<159: :AID-PPUL1>3.0.CO;2-1 1:STN:280:DyaK1MvivFSmtg%3D%3D (Pubitemid 29420280)
32. Siegel JD, Rhinehart E, Jackson M, Chiarello L; The Healthcare Infection Control Practices Advisory Committee (2006) Management of multidrug-resistant organisms in healthcare settings, 2006. Centers for Disease Control and Prevention (CDC), pp 1-74. Available online at: http://www.cdc.gov/ncidod/dhqp/ pdf/ar/MDROGuideline2006.pdf
33. National Committee for Clinical Laboratory Standards (NCCLS) (2002) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th edn. Approved Standard M7-A5. NCCLS, Wayne, PA
34. D Grothues U Koopmann H von der Hardt B Tümmler 1988 Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains J Clin Microbiol 26 1973 1977 3141456 1:STN:280:DyaL1M%2FjsVKrsA%3D%3D
35. FC Tenover RD Arbeit RV Goering PA Mickelsen BE Murray DH Persing B Swaminathan 1995 Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing J Clin Microbiol 33 2233 2239 7494007 1:CAS:528:DyaK2MXoslSisLc%3D
36. A Magni M Trancassini P Varesi V Iebba A Curci C Pecoraro G Cimino S Schippa S Quattrucci 2010 Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients J Clin Microbiol 48 1035 1039 20107101 10.1128/JCM.02060-09 1:CAS:528:DC%2BC3cXmt1Kgt7g%3D
37. S Van Daele R Verhelst G Claeys G Verschraegen H Franckx L Van Simaey C de Ganck F De Baets M Vaneechoutte 2005 Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center J Clin Microbiol 43 2998 3002 15956444 10.1128/JCM.43.6.2998-3002.2005 (Pubitemid 40827999)